PRA International Adds Dr. Susan Stansfield as Executive Vice...(nd development at rates comparable to or...),Health
Navigation Links
PRA International Adds Dr. Susan Stansfield as Executive Vice President
Date:9/5/2007
nd development at rates comparable to or greater than historical levels; trends or events affecting the CRO industry and the demand for CRO services; government regulation, including regulatory standards applicable to CRO services; evolving industry standards and technological changes; and general business and economic conditions. Events relating to PRA International could differ materially from those anticipated in these forward-looking statements. Although these statements are based upon assumptions company management believes to be reasonable based upon available information, they are subject to the foregoing risks and uncertainties as well as those described more fully in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our annual report on Form 10-K. This document can be accessed in the SEC's EDGAR database found at http://www.sec.gov. Please note that PRA International assumes no obligation to update any of the forward-looking statements in this release, except as required by applicable securities laws.
About PRA International
PRA International is one of the world's leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, South America, Africa, Australia, and Asia. PRA delivers services to its clients through a unique approach called Project Assurance(R), which represents the company's commitment to reliable service delivery, program-level therapeutic expertise, easy, global access to knowledge, and involved senior management.
To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.
'/>"/>
| SOURCE PRA International Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International conference on Ayurveda to be held on Kerala
9. International Teleradiology: The Future Of Radiologic Diagnosis
10. John Mendelsohn M.D, chosen for an International Award
11. Thailand To Procure Botulism Antitoxin Internationally
Post Your Comments:
(Date:7/25/2008)..., July 25 /PRNewswire/ -- BeaconEquity.com announc...ng news today., Investors can view all of the dai...conEquity.com/m , Today,s Trade Alerts include: D...rook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMe... ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis In...
(Date:7/25/2008)...Relationship Based on Significant Improvements in ... MDdatacor, Inc., a leader in health,care quality ...s, today,announced it has entered into a long-term...ort Wellmark,s Collaboration on Quality(SM) Incent...tion between Wellmark and,primary care clinicians ...
(Date:7/25/2008)...AD, Calif., July 25 /PRNewswire/ -- AutoGenomics, ...ion statement on Form S-1 with the,Securities and ...al public,offering of shares of its common stock. ..., all of which are expected to be offered by,AutoG...g, have not yet been,determined., J.P. Morgan Sec...
(Date:7/25/2008)... Whether you are an Olympian, Profe... there are Five Things You Need to Know about Hydr...C. Spine and Sports Center , ...- America,s premier athletes are heading to Beijin...g and sacrifice in the hopes of capturing an Olymp...
Breaking Medicine News(10 mins):Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5[0] BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX[0] MDdatacor Extends Contract with Wellmark, Inc.[0] AutoGenomics, Inc. Files Registration Statement for Initial Public Offering[0] Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know
...y increase a person’s risk of developing dementia ...e effect.// In a recent study conducted, researche...n 20 years. They found those who were obese in mid...dementia later in life. Also, patients who had hig...
...s toll on active baby boomers. Arthritis followed ...//for many of the 78 million middle-aged Americans... ahead. Michael Baroli is finally back on his feet... directing. His glamour photography business depen...
...cancer diagnosed among men in the United States --...e several // treatment options, but new research s...ogether. Doctors hope that the drug -- finasteri...ng prostate cancer. In smaller doses, it’s commonl...
... a way to diagnose melancholic depression using an.../ levels of certain substances in the brain. Melan...arked by insomnia, loss of appetite, and loss of p...evels of the inhibitory transmitter GABA and high ...
Other Medicine News:(Date:7/23/2008)...re/ -- The following was,released by the U.S. Depa...ber Smith, and Members of the Committee.,Thank you...ppeared before this Committee almost six months ag...alented and dedicated professionals,at the Justice...come to,appreciate that much more deeply their ser...
(Date:7/23/2008)...-- Dendreon Corporation,(Nasdaq: DNDN ) today ann...ring Committee (IDMC) to review in October 2008 th... the Company,s Phase 3 IMPACT (IMmunotherapy,for P...902B) clinical trial,of PROVENGE(R) (sipuleucel-T)... cellular immunotherapy for the treatment of advan...
(Date:7/22/2008)...in Medical, a leading innovator,of physiological m...tered,the clinical testing phase with its breakthr...ion. Today,s most common application for this,tech...l blood oxygenation,in the brain -- cerebral oxime...oing clinical study at the,Duke University Medical...
(Date:7/22/2008)...a Exhibits Excellent Drug-Like ...tiation of Phase II Clinical Trials -, RESEARCH T... BioPharma,Inc., a clinical stage company develop...diseases of the central nervous system, today anno...M) into Phase II trials for the,treatment of depre...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Nicotine addiction slashed in test of new cigarette smoking strategy 6279 1Nicotine addiction slashed in test of new cigarette smoking strategy 6279 2Nicotine addiction slashed in test of new cigarette smoking strategy 6279 3Synaptics SecurePad 28TM 29 Selected as CES Innovations 2008 Design and Engineering Award Honoree 1208 1Synaptics SecurePad 28TM 29 Selected as CES Innovations 2008 Design and Engineering Award Honoree 1208 2Synaptics SecurePad 28TM 29 Selected as CES Innovations 2008 Design and Engineering Award Honoree 1208 3Plastic Surgery Complications and Deaths are Rare Despite Highly Publicized Death of Donda West 6273 1Plastic Surgery Complications and Deaths are Rare Despite Highly Publicized Death of Donda West 6273 2Plastic Surgery Complications and Deaths are Rare Despite Highly Publicized Death of Donda West 6273 3Fortune 500 Executive Elected to AMA Board of Trustees 6267 1Fortune 500 Executive Elected to AMA Board of Trustees 6267 2[0] Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee[0] Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October[0] Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market[0] CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
...%; mso-hyphenate: none">,BUDAPEST, Hungary, June, ...ands of patients with cancer from suffering,unnece...gress of,the European Association for Palliative C...ted whether this first in class novel,formulation ...duration of effect, mirroring the breakthrough pai...
...IMPAX Laboratories,Inc. (OTC:IPXL) today announce...company,s compound, IPX054, a combined immediate-,...oduct to be,marketed as VADOVA(TM), were presented...onal Congress of Parkinson,s Disease and,Movement ... poster,presentations will be available in the Inv...
Other Medicine Technology:Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 2IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 3IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders 4Aegis CheckPoint is an automated, wireless, computerized remote temperature monitoring, recording, logging and alert system for refrigerator, freezer, incubator and water bath to replace chart record
This requiring no water for use, it provides convenient, long-lasting hand hygiene to physically clean hands when routine hand washing is either not an option or is not convenient. Hibistat allows yo
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri
Exidine® 2% CHG Brushless Surgical Scrub offers exceptional persistence and broad-spectrum antimicrobial activity.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |